KilgourMD

KilgourMD, Inc. is a U. S. -based company specializing in innovative scalp care products aimed at promoting hair growth and improving scalp health for women experiencing hair thinning during menopause.

KilgourMD, Inc. was founded in 2023 and is headquartered in Wilmington, US. The company focuses on developing scalp care solutions. In October 2025, it raised USD 5.

00 mn in funding led by Willow Growth Partners, with participation from Able Partners and Joyance Partners, bringing the total amount raised to USD 5. 00 mn. KilgourMD specializes in innovative scalp care products designed to promote hair growth and address scalp health challenges. The company's core offerings include the Prevention Scalp Serum and the Treatment Scalp Serum, which collectively form a dual-action system aimed at combating hair loss due to hormonal, environmental, and age-related factors.

Released to the market with a focus on women experiencing hair thinning, particularly during menopause, the products serve end users who seek a non-invasive solution to restore hair fullness and density. With a customer base that has expanded to over 50,000 women, KilgourMD products are marketed in various regions, including the United States, Canada, Australia, and several European countries, ensuring accessibility to those affected by hair loss. KilgourMD operates on a direct-to-consumer model, predominantly through subscription-based sales, which allows customers to receive products at regular intervals. The company offers several subscription plans, including options for one-month, two-month, and three-month supplies, each designed to provide savings for repeat customers.

The pricing structure features competitive discounts for subscriptions — with a one-month supply available for USD 127. 50, a two-month supply for USD 240. 00, and a three-month supply for USD 330. 00.

Each product is positioned as a premium offering, with the Prevention and Treatment Serums being the flagship items that drive sales. This approach enables KilgourMD to build a loyal customer base while maintaining a steady revenue stream from recurring orders. In March 2026, KilgourMD raised an undisclosed amount in series A funding led by Prelude Growth Partners, with participation from Willow Growth Partners, Able Partners, and Joyance Partners.